4//SEC Filing
Hancock Richard B 4
Accession 0001683168-23-008940
CIK 0000704562other
Filed
Dec 17, 7:00 PM ET
Accepted
Dec 18, 7:31 PM ET
Size
11.8 KB
Accession
0001683168-23-008940
Insider Transaction Report
Form 4
Hancock Richard B
Director
Transactions
- Purchase
Common Stock, $0.001 par value
2023-12-15$5.86/sh+23,000$134,734→ 78,760 total - Exercise/Conversion
Restricted Stock Units
2023-12-14−9,612→ 7,014 total→ Common Stock (9,612 underlying) - Exercise/Conversion
Common Stock, $0.001 par value
2023-12-14+9,612→ 55,760 total - Award
Restricted Stock Units
2023-12-14+26,756→ 33,770 total→ Common Stock (26,756 underlying)
Footnotes (5)
- [F1]Each restricted stock unit ("RSU") represents the contingent right to receive, upon vesting, one share of the Issuer's Common Stock.
- [F2]Represents a weighted average purchase price per share. These shares were purchased at prices ranging from $5.825 to $5.90. The Reporting Person has provided to the Issuer, and hereby undertakes to provide the SEC staff or a security holder of the Issuer, upon request, information regarding the number of shares purchased at each respective price within the range set forth in this footnote.
- [F3]RSUs granted to the reporting person on December 14, 2022 pursuant to the Issuer's non-employee director compensation program fully vested on December 14, 2023.
- [F4]Annual equity award grant pursuant to the Issuer's non-employee director compensation program.
- [F5]RSUs granted to the reporting person on December 14, 2023 shall fully vest on December 14, 2024, subject to the reporting person's continuous service to the Issuer on such vesting date.
Documents
Issuer
Avid Bioservices, Inc.
CIK 0000704562
Entity typeother
Related Parties
1- filerCIK 0001723288
Filing Metadata
- Form type
- 4
- Filed
- Dec 17, 7:00 PM ET
- Accepted
- Dec 18, 7:31 PM ET
- Size
- 11.8 KB